| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 45 | 6.883 | 39.920 | 68.673 | 63.154 | 77.262 | 85.796 | 80.198 | 92.914 |
| Total Income - EUR | - | 45 | 6.883 | 39.921 | 68.673 | 63.620 | 77.263 | 85.797 | 80.199 | 92.914 |
| Total Expenses - EUR | - | 3.778 | 21.500 | 35.036 | 52.083 | 56.562 | 76.297 | 72.653 | 79.410 | 95.300 |
| Gross Profit/Loss - EUR | - | -3.733 | -14.617 | 4.885 | 16.590 | 7.058 | 966 | 13.144 | 789 | -2.385 |
| Net Profit/Loss - EUR | - | -3.735 | -14.686 | 4.486 | 15.901 | 6.426 | 193 | 12.371 | -13 | -5.173 |
| Employees | - | 1 | 1 | 3 | 4 | 4 | 4 | 4 | 6 | 5 |
Check the financial reports for the company - Human Eurolab Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 6.276 | 6.468 | 6.194 | 5.199 | 4.072 | 7.287 | 6.087 | 8.326 | 6.732 |
| Current Assets | - | 5.106 | 6.362 | 12.667 | 30.809 | 23.449 | 22.801 | 25.155 | 22.058 | 24.558 |
| Inventories | - | 5.080 | 6.180 | 8.140 | 12.927 | 14.677 | 9.076 | 9.212 | 8.772 | 13.485 |
| Receivables | - | 0 | 109 | 3.170 | 12.843 | 7.010 | 10.721 | 12.786 | 9.074 | 7.135 |
| Cash | - | 25 | 72 | 1.356 | 5.039 | 1.762 | 3.004 | 3.156 | 4.213 | 3.938 |
| Shareholders Funds | - | -3.690 | -18.314 | -13.492 | 2.671 | 9.046 | 9.039 | 21.438 | 21.360 | 16.068 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 15.071 | 31.144 | 32.353 | 33.338 | 18.475 | 21.049 | 9.804 | 9.025 | 15.222 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8690 - 8690" | |||||||||
| CAEN Financial Year |
8690
|
|||||||||
Comments - Human Eurolab Srl